Hnp Capital LLC Vaccinex, Inc. Transaction History

Hnp Capital LLC

  • $356 Million
  • Q1 2023

A detailed history of Hnp Capital LLC transactions in Vaccinex, Inc. stock. As of the latest transaction made, Hnp Capital LLC holds 10,000 shares of VCNX stock, worth $11,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$11,900
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Aug 15, 2022
BUY
$0.92 - $1.94 $9,200 - $19,400
10,000 New
10,000 $13,000

Others Institutions Holding VCNX

# of Institutions
2
Shares Held
426K
Call Options Held
0
Put Options Held
0
View Full List

About VACCINEX, INC.

VCNX Quotes by TradingView
  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $50.8M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Hnp Capital LLC Portfolio

Follow Hnp Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hnp Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hnp Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email